Fuad El-Hibri

Chief Executive Officer, Emergent BioSolutions.

Companies

Aptevo Therapeutics Inc.Board member Aug 2, 2016 to Dec 7, 2021¹
Emergent BioSolutionsBoard member Apr 21, 2008 to Dec 7, 2021²
Emergent BioSolutionsChair Nov 14, 2006 to Feb 26, 2021³
Emergent BioSolutionsChief executive officer Nov 14, 2006 to Mar 30, 2012³
Emergent BioSolutionsPresident Nov 21, 2006 to Dec 15, 2006⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Emergent BioSolutions EBS1,343,405 shares⁵$8.7M at $6.46Dec 7, 2021
Aptevo Therapeutics Inc. APVO87,697 shares⁶$141.2K at $1.61Dec 7, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 3, 2021Other 206,434 shares of Emergent BioSolutions⁵
Dec 3, 2021Other 7,373 shares of Aptevo Therapeutics Inc.⁶
Dec 3, 2021Other 274,930 shares of Emergent BioSolutions⁵
Dec 3, 2021Other 9,819 shares of Aptevo Therapeutics Inc.⁶
Dec 3, 2021Other 3,018,644 shares of Emergent BioSolutions⁵
Dec 3, 2021Other 107,807 shares of Aptevo Therapeutics Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAptevo Therapeutics Inc., Board member
2
SEC EDGAREmergent BioSolutions, Board member
3
SEC EDGAREmergent BioSolutions, Chair
4
SEC EDGAREmergent BioSolutions, President
5
SEC EDGAREmergent BioSolutions shares after the filing of Dec 7, 2021
6
SEC EDGARAptevo Therapeutics Inc. shares after the filing of Dec 7, 2021